eMedicine Specialties > Urology > Hydronephrosis and Ureter Disorders

Urinary Tract Obstruction: Workup

Author: Edward David Kim, MD, FACS, Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center
Coauthor(s): Yvonne Katherine P Koch, MD, Physician, Department of Urology, Case Western Reserve University, University Hospitals of Cleveland; Suzette E Sutherland, MD, Adjunct Associate Professor, Department of Urologic Surgery, University of Minnesota Medical School; Metro Urology, Centers for Continence Care and Female Urology
Contributor Information and Disclosures

Updated: Oct 31, 2008

Workup

Laboratory Studies

  • Urinalysis
    • Urinalysis can provide useful information in evaluating for infection or hematuria.
    • WBCs in the urine can indicate infection or inflammation.
    • Nitrite- or leukocyte esterase–positive urine indicates infection.
    • All urine that contains WBCs or is positive for nitrite or leukocyte esterase should be sent for culture analysis and antibiotic susceptibility.
    • RBCs in the urine can be present in infection, stones, or tumor. A urologist should evaluate all patients with microscopic or gross hematuria to ensure that malignancy is not present. These patients require urine cytology and a full hematuria workup (cystoscopy, upper urinary tract imaging).
    • Urine pH is useful in the evaluation and workup of stones.
  • Basic metabolic panel
    • Renal insufficiency is detected on a basic metabolic panel based on elevated BUN and creatinine levels. This can result from bilateral renal obstructive processes or obstruction in a solitary kidney.
    • Other metabolic abnormalities can also be present in renal insufficiency. Hyperkalemia and acidosis may be present.
  • Complete blood cell count
    • Leukocytosis indicates infection.
    • Anemia can be due to acute processes (eg, blood loss) or chronic processes (eg, chronic renal insufficiency, malignancy).

Imaging Studies

  • Ultrasonography
    • Ultrasonography of the kidneys and bladder is a useful imaging modality as an initial study. It is a noninvasive inexpensive study that does not involve radiation exposure or depend on renal function. It is the initial study of choice in pregnant women.
    • In patients with intravenous pyelography (IVP) dye allergies or elevated creatinine levels, ultrasonography is a very useful source of imaging.
    • In children, this is often part of the initial workup for obstructive processes.
    • Ultrasonography is sensitive in revealing renal parenchymal masses, hydronephrosis, a distended bladder, and renal calculi.
    • The accuracy of this imaging modality depends heavily on the experience of the ultrasonographer.
    • In adults, if the ultrasonography findings are abnormal in any way, additional imaging is usually recommended. The combination of renal ultrasonography with flat-plate radiography of the kidneys, ureters, and bladder (KUB) is an inexpensive initial combination.
  • Computerized tomography scan
    • A CT scan is very useful in providing anatomic detail and is often a first-line test in the evaluation of a patient.
    • A CT scan provides information regarding the urinary tract, as well as any possible retroperitoneal or pelvic pathologic condition that can affect the urinary tract via direct extension or external compression.
    • A noncontrast CT scan should be obtained to assess for calculi. If calculi are found, flat-plate radiography of the abdomen (KUB) should be obtained to help determine calcium content and stone shape and to assist in monitoring the progress of the stone. Its progress can be observed with periodic simple radiography.
    • A contrasted CT scan is needed to provide information on renal pathology.
    • If delayed contrast images are obtained, CT urography with 3-dimensional reconstruction can provide excellent visualization of the entire upper urinary tracts. A CT scan can be used to identify or rule out any other intra-abdominal processes that can cause presenting symptoms (eg, appendicitis, cholecystitis, diverticulitis, abdominal aneurysms, ovarian cysts).
  • Intravenous pyelography
    • IVP involves the injection of dye into the venous system and a series of KUB radiographs over time.
    • It can be performed in patients with a normal creatinine value (<1.5 mg/dL) for visualization of the upper urinary tract.
    • It provides both anatomical and functional information.
    • Delayed calyceal filling, delayed contrast excretion, prolonged nephrography results, and dilatation of the urinary tract proximal to the point of obstruction characterize obstruction.
    • IVP is superior to CT scan in revealing small urothelial upper tract lesions.
    • If IVP is inadequate, retrograde pyelography can be performed to completely visualize the renal pelvis or ureter.
    • Patients with IVP dye allergy cannot undergo this test.
    • A combination CT scan and IVP (CT/IVP) test is commonplace. With this combined technique, both modalities can be used. CT urography, as mentioned above (see Computerized tomography scan), is also an excellent modality.
  • Radionucleotide studies: A renal scan can be performed to determine the differential function of the kidneys, as well as to demonstrate the concentrating ability, excretion, and drainage of the urinary tract. Lasix can be administered with the renal scan to verify delayed excretion and the presence of obstruction.
  • Magnetic resonance imaging
    • MRI is not a first-line test used to evaluate the urinary tract.
    • In patients who cannot tolerate a CT scan with contrast, an MRI with gadolinium can be performed to reveal any enhancing renal lesions.
    • MRI is useful in delineating specific tissue planes for surgical planning, as well as in evaluating the presence or extent of a renal vein or inferior vena cava thrombus in cases of renal tumors.
    • MRI does not reveal urinary stones well so is not often used as a first-line test.
  • Retrograde urethrography: Radiographic dye is injected into the urethral meatus via Foley catheter at the distal urethra. Fluoroscopy is used to visualize the entire urethra for stricture or any abnormalities. This test can be particularly useful in working up lower urinary tract trauma.
  • Retrograde pyelography: See Cystoscopy with retrograde pyelography.
  • Nephrostography: This can be performed in patients who have a nephrostomy tube in place. Radiographic dye is injected antegrade through the nephrostomy tube. With fluoroscopy, any abnormalities or filling defects in the renal pelvis or ureter are visible. This can be safely performed even in patients with IVP contrast allergies.

Diagnostic Procedures

  • Cystoscopy: Cystoscopy is the placement of a small camera called a cystoscope through the urethral meatus and passing through the urethra into the bladder. Any abnormalities in the urethra, prostatic urethra, bladder neck, and bladder can be visualized. This can be performed in the office or in the operating room.
  • Cystoscopy with retrograde pyelography: Retrograde pyelography is performed in the operating room with a cystoscope in the bladder. Radiographic dye is injected into each ureteral orifice. Then, with the use of fluoroscopy, any ureteral or renal pelvis filling defects or abnormalities can be visualized. The contrast load does not interfere with renal function and can be used in patients with elevated creatinine levels. It can also be used in patients with an IVP dye allergy because the contrast remains extravascular.

Histologic Findings

When upper urinary tract obstruction occurs, the kidney undergoes interstitial fibrosis, with the accumulation of collagens and other extracellular matrix components.

Staging

No staging system exists for urinary tract obstruction.

More on Urinary Tract Obstruction

Overview: Urinary Tract Obstruction
Workup: Urinary Tract Obstruction
Treatment: Urinary Tract Obstruction
Follow-up: Urinary Tract Obstruction
Multimedia: Urinary Tract Obstruction
References

References

  1. Loo MH, Vaughan ED. Obstructive nephropathy and postobstructive diuresis. AUA Update Series. 1985;4:9.

  2. Campbell SC, Walsh PC. Pathophysiology of urinary tract obstruction. In: Wein J, ed. Campbell-Walsh Urology. Vol 2. 9th ed. Saunders; 2007:1195-226.

  3. Chen MY, Zagoria RJ, Dyer RB. Radiologic findings in acute urinary tract obstruction. J Emerg Med. May-Jun 1997;15(3):339-43. [Medline].

  4. Follis HW, Koch MO, McDougal WS. Immediate management of prostatomembranous urethral disruptions. J Urol. May 1992;147(5):1259-62. [Medline].

  5. Franke JJ, Smith JA. Surgery of the ureter. In: Walsh PC, Retik AB, eds. Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders and Co; 1998.

  6. Gulmi FA, Felsen D, Vaughan ED. The pathophysiology of urinary tract obstruction. In: Walsh PC, Retik AB, eds. Campbell's Urology. 7th ed. Philadephia, Pa: WB Saunders and Co; 1998:342-385.

  7. Hampel N. Posterior urethral disruption associated with pelvic fracture: the place for delayed repair. Semin Urol. Feb 1995;13(1):34-7. [Medline].

  8. Kabalin JN. Surgical anatomy of the retroperitoneum, kidneys, and ureters. In: Walsh PC, Retik AB, eds. Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders and Co; 1998.

  9. Lefort C, Marouteau-Pasquier N, Pesquet AS, Pfister C, Vera P, Dacher JN. Dynamic MR urography in urinary tract obstruction: implementation and preliminary results. Abdom Imaging. Mar-Apr 2006;31(2):232-40. [Medline].

  10. Lloyd-Davies RW. Landmarks in the History of Urology. In: Weiss RM, George NJR, O'Reilly PH, eds. Comprehensive Urology. England, UK: Mosby; 2001:1-14.

  11. Macfarlane MT. Obstructive uropathy. In: Urology. 2nd ed. Philadelphia, Pa: Williams & Wilkins; 1995:97-102.

  12. McNaughton-Collins M, Barry MJ. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Am J Med. Dec 2005;118(12):1331-9. [Medline].

  13. Resnick MI, Kursh ED. Extrinsic obstruction of the ureter. In: Walsh PC, Retik AB, eds. Campbell's Urology. Vol 1. Philadelphia, Pa: WB Saunders and Co; 1998:387-422.

  14. Sty JR, Pan CG. Genitourinary imaging techniques. Pediatr Clin North Am. Jun 2006;53(3):339-61, v. [Medline].

  15. Tanagho EA. Urinary obstruction and stasis. In: Tanagho EA, McAninch JW, eds. Smith's General Urology. New York, NY: McGraw-Hill; 1995:172-185.

  16. Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int. Dec 2005;96(9):1301-6. [Medline].

  17. Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol. Nov 2005;174(5):1887-91. [Medline].

Further Reading

Keywords

urinary tract obstruction, obstructive uropathy, obstructive nephropathy, lower urinary tract obstruction, upper urinary tract obstruction, hydronephrosis, hydroureteronephrosis, urethral catheter, urethral catheterization, suprapubic catheter, ureteral stent, nephrostomy tube

Contributor Information and Disclosures

Author

Edward David Kim, MD, FACS, Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center
Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, and Tennessee Medical Association
Disclosure: Lilly Consulting fee Consulting; Astellas Consulting fee Speaking and teaching; Indevus Consulting fee Speaking and teaching

Coauthor(s)

Yvonne Katherine P Koch, MD, Physician, Department of Urology, Case Western Reserve University, University Hospitals of Cleveland
Yvonne Katherine P Koch, MD is a member of the following medical societies: American Urological Association and Endourological Society
Disclosure: Nothing to disclose.

Suzette E Sutherland, MD, Adjunct Associate Professor, Department of Urologic Surgery, University of Minnesota Medical School; Metro Urology, Centers for Continence Care and Female Urology
Suzette E Sutherland, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Urological Association, International Continence Society, International Society for Sexual Medicine, and Minnesota Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Gyrus-ACMI Honoraria Speaking and teaching

Chief Editor

Bradley Fields Schwartz, DO, FACS, Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.